UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 381

Sortiert nach

Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance

Nature structural & molecular biology, 2010-09, Vol.17 (9), p.1152

2010

Volltextzugriff (PDF)

Asymmetric Synthesis of the Fully Elaborated Pyrrolidinone Core of Oxazolomycin A

Organic letters, 2012-11, Vol.14 (21), p.5460-5463

2012

Volltextzugriff (PDF)

Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis

Journal of medicinal chemistry, 2021-05, Vol.64 (9), p.5905-5930

2021

Volltextzugriff (PDF)

Structure-Guided Design and Synthesis of a Pyridazinone Series of Trypanosoma cruzi Proteasome Inhibitors

Journal of medicinal chemistry, 2023-08, Vol.66 (15), p.10413-10431

2023

Volltextzugriff (PDF)

Identification and Optimization of a Series of 8‑Hydroxy Naphthyridines with Potent In Vitro Antileishmanial Activity: Initial SAR and Assessment of In Vivo Activity

Journal of medicinal chemistry, 2020-09, Vol.63 (17), p.9523-9539

2020

Volltextzugriff (PDF)

Antitrypanosomal 8-Hydroxy-Naphthyridines Are Chelators of Divalent Transition Metals

Antimicrobial agents and chemotherapy, 2018-08, Vol.62 (8)

2018

Volltextzugriff (PDF)

Novel tricyclics (e.g., GSK945237) as potent inhibitors of bacterial type IIA topoisomerases

Bioorganic & medicinal chemistry letters, 2016-05, Vol.26 (10), p.2464-2469

2016

Volltextzugriff (PDF)

Unsaturated 1,2-amino alcohols and ethers from aziridines and organolithiums

Chemical communications (Cambridge, England), 2004-01 (19), p.2234-2235

2004

Volltextzugriff (PDF)

Novel hydroxyl tricyclics (e.g., GSK966587) as potent inhibitors of bacterial type IIA topoisomerases

Bioorganic & medicinal chemistry letters, 2013-10, Vol.23 (19), p.5437-5441

2013

Volltextzugriff (PDF)

Optimisation of a key cross-coupling reaction towards the synthesis of a promising antileishmanial compound

Tetrahedron letters, 2019-05, Vol.60 (18), p.1243-1247

2019

Volltextzugriff (PDF)

The Qi Site of Cytochrome b is a Promiscuous Drug Target in Trypanosoma cruzi and Leishmania donovani

ACS infectious diseases, 2020-03, Vol.6 (3), p.515-528

2020

Volltextzugriff (PDF)

Novel amino-piperidines as potent antibacterials targeting bacterial type IIA topoisomerases

Bioorganic & medicinal chemistry letters, 2011-12, Vol.21 (24), p.7489-7495

2011

Volltextzugriff (PDF)

Novel cyclohexyl-amides as potent antibacterials targeting bacterial type IIA topoisomerases

Bioorganic & medicinal chemistry letters, 2011-12, Vol.21 (24), p.7483-7488

2011

Volltextzugriff (PDF)

Identification of 6-amino-1H-pyrazolo[3,4-d]pyrimidines with in vivo efficacy against visceral leishmaniasis

RSC medicinal chemistry, 2020-10, Vol.11 (10), p.1168-1177

2020

Volltextzugriff (PDF)

The Q i Site of Cytochrome b is a Promiscuous Drug Target in Trypanosoma cruzi and Leishmania donovani

ACS infectious diseases, 2020-03, Vol.6 (3), p.515-528

2020

Volltextzugriff (PDF)

Identification of 6-amino-1 H -pyrazolo[3,4- d ]pyrimidines with in vivo efficacy against visceral leishmaniasis

RSC medicinal chemistry, 2020-10, Vol.11 (10), p.1168-1177

2020

Volltextzugriff (PDF)

Organolithium-Induced Alkylative Ring Opening of Aziridines: Synthesis of Unsaturated Amino Alcohols and Ethers

Journal of organic chemistry, 2006-10, Vol.71 (22), p.8510-8515

2006

Volltextzugriff (PDF)

Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition

Proceedings of the National Academy of Sciences - PNAS, 2019-05, Vol.116 (19), p.9318-9323

2019

Volltextzugriff (PDF)

Organolithium-induced synthesis of acyclic unsaturated amino alcohols from epoxides of dihydropyrroles and tetrahydropyridines

Tetrahedron, 2003-12, Vol.59 (49), p.9729-9742

2003

Volltextzugriff (PDF)

Enantioselective Alkylative Double Ring Opening of Epoxides: Synthesis of Enantioenriched Unsaturated Diols and Amino Alcohols

Angewandte Chemie (International ed.), 2002-11, Vol.41 (22), p.4313-4316

2002

Volltextzugriff (PDF)

Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis

Journal of medicinal chemistry, 2019-02, Vol.62 (3), p.1180-1202

2019

Volltextzugriff (PDF)

1 – 25 von 381

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(342)
Mit Volltextzugriff
(334)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(380)
Japanisch
(64)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(278)
Life Sciences & Biomedicine
(221)
Humans
(189)
Male
(101)
Female
(83)
Adult
(75)
Middle Aged
(61)
Biological And Medical Sciences
(58)
Animals
(51)
Medical Sciences
(44)
Physical Sciences
(44)
Aged
(39)
Oncology
(25)
Chemistry
(24)
Surgery
(23)
Mice
(22)
Science & Technology - Other Topics
(22)
Neurosciences & Neurology
(21)
Fundamental And Applied Biological Sciences. Psychology
(20)
Neurosciences
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance

Asymmetric Synthesis of the Fully Elaborated Pyrrolidinone Core of Oxazolomycin A

Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis

Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis

Structure-Guided Design and Synthesis of a Pyridazinone Series of Trypanosoma cruzi Proteasome Inhibitors

Author Correction: Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis

Discovery and Optimization of 5‑Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi

Identification and Optimization of a Series of 8‑Hydroxy Naphthyridines with Potent In Vitro Antileishmanial Activity: Initial SAR and Assessment of In Vivo Activity

Antitrypanosomal 8-Hydroxy-Naphthyridines Are Chelators of Divalent Transition Metals

Novel tricyclics (e.g., GSK945237) as potent inhibitors of bacterial type IIA topoisomerases

Unsaturated 1,2-amino alcohols and ethers from aziridines and organolithiums

Novel hydroxyl tricyclics (e.g., GSK966587) as potent inhibitors of bacterial type IIA topoisomerases

Optimisation of a key cross-coupling reaction towards the synthesis of a promising antileishmanial compound

The Qi Site of Cytochrome b is a Promiscuous Drug Target in Trypanosoma cruzi and Leishmania donovani

Novel amino-piperidines as potent antibacterials targeting bacterial type IIA topoisomerases

Novel cyclohexyl-amides as potent antibacterials targeting bacterial type IIA topoisomerases

Identification of 6-amino-1H-pyrazolo[3,4-d]pyrimidines with in vivo efficacy against visceral leishmaniasis

Setting Our Sights on Infectious Diseases

The Q i Site of Cytochrome b is a Promiscuous Drug Target in Trypanosoma cruzi and Leishmania donovani

Identification of 6-amino-1 H -pyrazolo[3,4- d ]pyrimidines with in vivo efficacy against visceral leishmaniasis

Organolithium-Induced Alkylative Ring Opening of Aziridines: Synthesis of Unsaturated Amino Alcohols and Ethers

Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition

Organolithium-induced synthesis of acyclic unsaturated amino alcohols from epoxides of dihydropyrroles and tetrahydropyridines

Enantioselective Alkylative Double Ring Opening of Epoxides: Synthesis of Enantioenriched Unsaturated Diols and Amino Alcohols

Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis

Suchergebnisse filtern